相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CLEC-2 is required for development and maintenance of lymph nodes
Cecile Benezech et al.
BLOOD (2014)
Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life
Paul R. Hess et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Comparative rheology of the adhesion of platelets and leukocytes from flowing blood: why are platelets so small?
Tim Watts et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Combined In Vivo Depletion of Glycoprotein VI and C-Type Lectin-Like Receptor 2 Severely Compromises Hemostasis and Abrogates Arterial Thrombosis in Mice
Markus Bender et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
Huiying Zhi et al.
BLOOD (2013)
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and FcγRIIa in immune thrombocytopenia
Rolf T. Urbanus et al.
HAEMATOLOGICA (2013)
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
Brett H. Herzog et al.
NATURE (2013)
The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
Silvia Goebel et al.
PLOS ONE (2013)
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
Brenda A. Finney et al.
BLOOD (2012)
Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels
Mohammad Al-Tamimi et al.
BLOOD (2012)
The future of glycoprotein VI as an antithrombotic target
M. Zahid et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Platelet GPVI: a target for antithrombotic therapy?!
Sebastian Duetting et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
A Humanized Glycoprotein VI (GPVI) Mouse Model to Assess the Antithrombotic Efficacies of Anti-GPVI Agents
Pierre Henri Mangin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Tetraspanin microdomains: fine-tuning platelet function
Elizabeth J. Haining et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly et al.
BLOOD (2011)
Critical role for Syk in responses to vascular injury
Patrick Andre et al.
BLOOD (2011)
CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
Moritz Stolla et al.
BLOOD (2011)
Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans
Martin Ungerer et al.
CIRCULATION (2011)
Syk-dependent Phosphorylation of CLEC-2 A NOVEL MECHANISM OF HEM-IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF SIGNALING
Sonia Severin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ischaemic stroke: a thrombo-inflammatory disease?
Bernhard Nieswandt et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Mechanisms underlying FeCl3-induced arterial thrombosis
A. Eckly et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Genetic and antibody-induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl3-induced thrombosis
M. Bender et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury
Beatrice Hechler et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Platelet-Leukocyte Interactions in Cardiovascular Disease and Beyond
Licia Totani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
A central role of GPIb-IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbα N-terminal extracellular domain
Catherine Ravanat et al.
BLOOD (2010)
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling
Cara C. Bertozzi et al.
BLOOD (2010)
Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke
B. Bigalke et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2 EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETS
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Impact of glycoprotein VI and platelet adhesion on atherosclerosis-A possible role of fibronectin
Andreas Bueltmann et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
GPVI and CLEC-2 in hemostasis and vascular integrity
S. P. Watson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Antiplatelet therapies for the treatment of cardiovascular disease
Alan D. Michelson
NATURE REVIEWS DRUG DISCOVERY (2010)
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Eric Boilard et al.
SCIENCE (2010)
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations
Benedicte Dumont et al.
BLOOD (2009)
CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
Frauke May et al.
BLOOD (2009)
Heparin-induced thrombocytopenia
A. Greinacher
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model
M. J. E. Kuijpers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder
C. Hermans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets
Brian Boylan et al.
BLOOD (2008)
A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex
Hiroshi Takayama et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Evaluation of the physiological significance of botrocetin/von Willebrand factor in vitro signaling
J. Liu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression
P. Ohlmann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Platelet glycoprotein VI-related clinical defects
Jane F. Arthur et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Tamer Rabie et al.
BLOOD (2007)
The fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats
Haiquan Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Targeting platelets in acute experimental stroke - Impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding
Christoph Kleinschnitz et al.
CIRCULATION (2007)
Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis
S. Konstantinides et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice
Valerie Schulte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency
Pierre Mangin et al.
BLOOD (2006)
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo
Christophe Dubois et al.
BLOOD (2006)
Laminin stimulates spreading of platelets through integrin α6β1-dependent activation of GPVI
O Inoue et al.
BLOOD (2006)
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
K Suzuki-Inoue et al.
BLOOD (2006)
The integrin α6β1 modulation of PI3K and Cdc42 activities induces dynamic filopodium formation in human platelets
JC Chang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions
JMEM Cosemans et al.
ATHEROSCLEROSIS (2005)
Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice
S Grüner et al.
BLOOD (2005)
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms:: modulation of cytokine and platelet responses to IV anti-D by FcγRIIa and FcγRIIIa polymorphisms
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Anti-GPVI-associated ITP:: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface
B Boylan et al.
BLOOD (2004)
Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced α2β1 levels or concomitant aspirin therapy
S Grüner et al.
CIRCULATION (2004)
Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor γ-chain
T Bori-Sanz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion
K Kato et al.
BLOOD (2003)
Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
V Schulte et al.
BLOOD (2003)
Human platelet glycoprotein VI function is antagonized by monoclonal anti body-derived Fab fragments
C Lecut et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The Fc receptor γ-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin
O Berlanga et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus
H Takahashi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice
B Nieswandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
分享论文
